Stifel analyst, Rick Wise, reiterated his Buy rating on shares of Edwards Lifesciences (NYSE: EW) but expects the stock to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE